Literature DB >> 16412002

The prevalence of major abnormalities of the levator ani in urogynaecological patients.

H P Dietz1, A B Steensma.   

Abstract

OBJECTIVES: While morphological abnormalities of the pubovisceral muscle have been described on magnetic resonance imaging (MRI), their relevance remains unclear. This study was designed to define prevalence and clinical significance of such abnormalities in urogynaecological patients.
DESIGN: Prospective observational study.
SETTING: Tertiary urogynaecological clinic. POPULATION: Three hundred and thirty-eight consecutive women referred for urodynamic assessment.
METHODS: Participants underwent a clinical assessment, multichannel urodynamics and imaging with 3D translabial ultrasound. Blinded offline analysis was performed with the software 4D View (GE Kretztechnik, Zipf, Austria). MAIN OUTCOME MEASURES: Major morphological abnormalities of the pubovisceral muscle.
RESULTS: Defects of the pubovisceral muscle were found in 15.4% of parous women. They were exclusively anteromedial (uni- or bilateral), only occurred among women who had delivered vaginally and were associated with anterior and central compartment prolapse (all P<0.001). There was no association with symptoms of bladder dysfunction or urodynamic findings.
CONCLUSIONS: Major morphological abnormalities of the pubovisceral muscle are common in parous urogynaecological patients. They are associated with prolapse of the anterior and central compartment, but not with symptoms of bladder dysfunction or urodynamic findings.

Entities:  

Mesh:

Year:  2006        PMID: 16412002     DOI: 10.1111/j.1471-0528.2006.00819.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  55 in total

Review 1.  Pelvic floor ultrasound in incontinence: what's in it for the surgeon?

Authors:  Hans Peter Dietz
Journal:  Int Urogynecol J       Date:  2011-04-22       Impact factor: 2.894

2.  Ultrasound measurement of vaginal wall thickness: a novel and reliable technique.

Authors:  Demetri C Panayi; G Alessandro Digesu; Paris Tekkis; Ruwan Fernando; Vikram Khullar
Journal:  Int Urogynecol J       Date:  2010-05-26       Impact factor: 2.894

3.  Comment on Vergeldt et al.: Risk factors for pelvic organ prolapse and its recurrence: a systematic review.

Authors:  Ka Lai Shek; Hans Peter Dietz
Journal:  Int Urogynecol J       Date:  2016-02-06       Impact factor: 2.894

4.  Response to the letter to the editor by Shek et al. on Vergeldt et al: Risk factors for pelvic organ prolapse and its recurrence: a systematic review.

Authors:  Tineke F M Vergeldt; Mirjam Weemhoff; Joanna IntHout; Kirsten B Kluivers
Journal:  Int Urogynecol J       Date:  2016-02-06       Impact factor: 2.894

5.  Levator ani defects in patients with stress urinary incontinence: three-dimensional endovaginal ultrasound assessment.

Authors:  Aparna Hegde; Vivian C Aguilar; G Willy Davila
Journal:  Int Urogynecol J       Date:  2016-07-08       Impact factor: 2.894

Review 6.  The aetiology of prolapse.

Authors:  H P Dietz
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-08-02

7.  Agreement between palpation and transperineal and endovaginal ultrasound in the diagnosis of levator ani avulsion.

Authors:  Kim W M van Delft; Abdul H Sultan; Ranee Thakar; S Abbas Shobeiri; Kirsten B Kluivers
Journal:  Int Urogynecol J       Date:  2014-05-24       Impact factor: 2.894

8.  Prolapse symptoms are associated with abnormal functional anatomy of the pelvic floor.

Authors:  Zeelha Abdool; Hans Peter Dietz; Barend Gerhardus Lindeque
Journal:  Int Urogynecol J       Date:  2017-02-02       Impact factor: 2.894

9.  Levator avulsion and grading of pelvic floor muscle strength.

Authors:  H P Dietz; C Shek
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-11-13

10.  Translabial three-dimensional ultrasound investigation of the levator hiatus in postpartum women.

Authors:  Xue-Mei Wang; Xin Chang; Yan Ding; Su-Zhen Wang; Yin Zhen; Jing-Xin Ding; Fan-Bin Kong
Journal:  J Med Ultrason (2001)       Date:  2015-01-09       Impact factor: 1.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.